Literature DB >> 14007701

Immunological studies with group B arthropod-borne viruses. III. Response of human subjects to revaccination with 17D strain yellow fever vaccine.

C L WISSEMAN, B H SWEET.   

Abstract

Entities:  

Keywords:  ENCEPHALITIS, JAPANESE B/immunology; YELLOW FEVER/immunology

Mesh：

Substances：

Year:  1962        PMID： 14007701

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  5 in total

1.  Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Authors:  Enoch Muyanja; Aloysius Ssemaganda; Pearline Ngauv; Rafael Cubas; Helene Perrin; Divya Srinivasan; Glenda Canderan; Benton Lawson; Jakub Kopycinski; Amanda S Graham; Dawne K Rowe; Michaela J Smith; Sharon Isern; Scott Michael; Guido Silvestri; Thomas H Vanderford; Erika Castro; Giuseppe Pantaleo; Joel Singer; Jill Gillmour; Noah Kiwanuka; Annet Nanvubya; Claudia Schmidt; Josephine Birungi; Josephine Cox; Elias K Haddad; Pontiano Kaleebu; Patricia Fast; Rafick-Pierre Sekaly; Lydie Trautmann; Denis Gaucher
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

2.  [Arbovirus in Cameroon: serologic investigation].

Authors:  J J Salaün; H Brottes
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

Review 3.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

4.  Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.

Authors:  Stephen J Thomas; Ananda Nisalak; Kathryn B Anderson; Daniel H Libraty; Siripen Kalayanarooj; David W Vaughn; Robert Putnak; Robert V Gibbons; Richard Jarman; Timothy P Endy
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

5.  Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination.

Authors:  Michael Kongsgaard; Maria R Bassi; Michael Rasmussen; Karsten Skjødt; Søren Thybo; Mette Gabriel; Morten Bagge Hansen; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Soren Buus; Anette Stryhn
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.